US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 12.27% Upside Potential Amid Strategic Advancements

Haemonetics Corporation (NYSE: HAE) stands as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.87 billion,..

Ultragenyx Pharmaceutical Inc. (RARE)

⚠️ No article content returned.

..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a Biotech Powerhouse with Growth Potential

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a prominent player in the biotechnology sector, leveraging its expertise to address rare disorders with innovative solutions. Headquartered in..

TransMedics Group, Inc. (TMDX) Stock Analysis: Promising Growth and Robust Ratings Signal Strong Investor Potential

TransMedics Group, Inc. (NASDAQ: TMDX), a leader in medical devices within the healthcare sector, has garnered significant attention from investors due to its innovative approach to..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Unpacking the 23% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is carving out a niche in the biopharmaceutical landscape by targeting rare neuroendocrine diseases with its innovative treatments. With a focus..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a Complex Biotech Landscape with a 7.53 Forward P/E Ratio

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a noteworthy player in the biotechnology sector, focusing on transformative therapies for rare genetic diseases. Despite navigating a challenging..

Alkermes plc (ALKS) Stock Analysis: A Biopharmaceutical Innovator with a 54% Potential Upside

Alkermes plc (NASDAQ: ALKS), a leader in the healthcare sector specializing in drug manufacturing, particularly in specialty and generic pharmaceuticals, has caught the attention of investors..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility with Strategic Partnerships and a Diverse Pipeline

Moderna, Inc. (NASDAQ: MRNA), a leading player in the biotechnology sector, remains at the forefront of medical innovation with its groundbreaking work in messenger RNA (mRNA)..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with a 12.42% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its focus on transformative medicines..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Deep Dive into Its 362% Revenue Growth and Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL) is capturing the attention of investors with its impressive revenue growth and promising analyst ratings. As a key player in the biotechnology..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a Solid 7.9% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Molina Healthcare Inc (NYSE: MOH) presents an intriguing prospect. With a robust market cap of $8.87 billion, this..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring Growth in the Booming Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) is carving out a significant niche in the healthcare sector, specifically within health information services. With a market capitalization of $6.76..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 15% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is making waves with its recent stock performance and forward-looking potential. As a key player..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Promising Biotech with 137% Upside Potential Awaits Investors

Investors in the biotechnology sector are no strangers to high-risk, high-reward scenarios, and Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity. With a market cap..

Henry Schein, Inc. (HSIC): Exploring Analyst Consensus and Growth Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector, is drawing the attention of investors as a stalwart in the medical distribution industry. With..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unpacking the Upside Potential in Transformative Biotech

In the dynamic world of biotechnology, Akero Therapeutics, Inc. (NASDAQ: AKRO) has been capturing investor attention with its focused strategy on developing groundbreaking treatments for metabolic..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 98% Upside in Biotechnology

Investors and analysts alike are taking a keen interest in Vaxcyte, Inc. (PCVX), a burgeoning force in the biotechnology sector with a market capitalization of $6.08..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 15% Potential Upside in Eye-Care Innovation

Alcon Inc. (NYSE: ALC), a global leader in the eye care sector, stands as a formidable player in the healthcare industry, with an impressive market cap..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Biotechnology Innovator with 434% Revenue Growth Awaits Investor Attention

Avidity Biosciences, Inc. (NASDAQ: RNA) is a promising name in the biotechnology sector, captivating investor attention with its impressive revenue growth and innovative RNA therapeutic solutions...

Chemed Corp (CHE) Stock Analysis: Valuation Insights and 31.91% Potential Upside

Investors with a keen interest in the healthcare sector may find Chemed Corp (NYSE: CHE) a compelling prospect, particularly given its significant potential upside of 31.91%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds